Special Session 3
Topic: Advanced Nanomaterials for Clinical Theranostics
Organizer: Prof. Lin Huang, Shanghai Chest Hospital, Shanghai Jiao Tong University, China
Introduction:
The integration of advanced nanomaterials into clinical
theranostics offers a powerful route to more precise,
non-invasive, and personalized management of major
diseases. However, conventional diagnostic and
therapeutic strategies still face major limitations,
including insufficient sensitivity and specificity, poor
tissue penetration of imaging probes, lack of real-time
monitoring, and systemic side effects of treatments.
These challenges are particularly prominent in the early
diagnosis and treatment of tumor malignancies and
cardiovascular diseases, where delayed detection and
limited prognostic accuracy significantly hinder patient
outcomes.
Recent progress in nanomedicine has highlighted the
unique advantages of functional nanomaterials, such as
high surface-to-volume ratios, tunable physicochemical
properties, and the capacity to co-deliver imaging
agents and therapeutic payloads. When combined with mass
spectrometry, biosensing, and artificial intelligence,
advanced nanomaterials can serve as integrated platforms
for high-throughput molecular profiling, sensitive
disease detection, and image-guided therapy.
This special session aims to bring together researchers
from materials science, biomedical engineering,
analytical chemistry, and clinical medicine to discuss
recent advances in the design and application of
advanced nanomaterials for clinical theranostics. The
session will focus on the development of multifunctional
nanomaterials and nano-bio interfaces, their integration
with diagnostic and therapeutic modalities, and their
clinical translation, with a particular emphasis on
improving early diagnosis, treatment precision, and
patient prognosis in cancerous and cardiovascular
diseases.
Submission Link:
https://confsys.iconf.org/submission/icnst2026
**Log in and choose "Special Session 3"
Lin Huang
Shanghai Chest Hospital, Shanghai Jiao Tong University, China
Prof. Lin Huang is Director of the Basic Medical Research Center at Shanghai Chest Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, and a doctoral supervisor. She serves as Principal Investigator of the Shanghai Thoracic Tumor Research Institute, Head of the Mass Spectrometry Center, and Deputy Director of the Chest Tumor Marker Translation Center at the Shanghai Experimental Medicine Research Institute. She has been selected for the National Science Fund for Excellent Young Scholars, the Shanghai High-level Talents Program (Double Hundred Talents Plan), the Shanghai Women's Innovation New Star Award, and the Shanghai Yangfan Talent Program.